An Open-label, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic Clonic Seizures in Subjects With Idiopathic Generalized Epilepsy

Trial Profile

An Open-label, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic Clonic Seizures in Subjects With Idiopathic Generalized Epilepsy

Recruiting
Phase of Trial: Phase III

Latest Information Update: 06 Aug 2017

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Generalised seizures; Tonic-clonic epilepsy
  • Focus Adverse reactions
  • Acronyms VALUE
  • Sponsors UCB
  • Most Recent Events

    • 01 Jul 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov record.
    • 30 Apr 2015 Planned initiation date changed from 1 Mar 2015 to 1 May 2015, as reported by ClinicalTrials.gov.
    • 09 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top